Subtotal: R15 000,00
MAGTIDLIRA 33
R2 600,00
UPA TIDLIRA 30MG PEN is a dual-agonist peptide with GLP-1 and GIP receptors which helps one lose fat loss, improve metabolic balance and suppresses one’s appetite.
Guarantee safe & secure checkout
On all order
Description
MAGTIDLIRA 33™ – Dual-Action Weight Loss Pen
(Semaglutide 3 mg + Tirzepatide 30 mg)
The Ultimate Synergy for Appetite Control, Fat Reduction & Metabolic Optimization
Experience the next evolution in GLP-1 therapy with MAGTIDLIRA 33™, a breakthrough dual-action injectable combining Semaglutide and Tirzepatide for unmatched weight-loss performance and metabolic balance.
Additional information
| Colour | Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow |
|---|
Quick Comparison
| MAGTIDLIRA 33 remove | BP Semag 6 remove | BP Tirze 30 remove | BP Retat 64 remove | HDL Tirze 30 remove | BP Retat 32 remove | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | MAGTIDLIRA 33 remove | BP Semag 6 remove | BP Tirze 30 remove | BP Retat 64 remove | HDL Tirze 30 remove | BP Retat 32 remove | ||||||||||||
| Image | | | | | | | ||||||||||||
| SKU | IN_LK-38 | IN_LK-5 | IN_LK-6 | IN_LK-4 | IN_LK-13 | IN_LK-3 | ||||||||||||
| Rating | ||||||||||||||||||
| Price | R2 600,00 | R2 500,00 | R2 800,00 | R4 300,00 | R2 100,00 | R3 600,00 | ||||||||||||
| Stock | ||||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Additional information |
|
|
|
|
|
| ||||||||||||
| Description | UPA TIDLIRA 30MG PEN is a dual-agonist peptide with GLP-1 and GIP receptors which helps one lose fat loss, improve metabolic balance and suppresses one's appetite. |
| BodyPharm (BP) Tirzepatide 30mg is a high-concentration research compound designed to mimic the action of hormones that manage blood sugar and appetite, primarily marketed in South Africa for laboratory use. [1, 2] |
| Experience the dual-action power of Tirzepatide 30mg from The Clinic, a next-generation injectable peptide designed to target two key hormone pathways: GLP-1 and GIP. |
| ||||||||||||
| Add to cart |
Reviews
There are no reviews yet.